KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome

Blood

Volumn 125, Issue 15, 2015, Pages 2405-2417

  Magor, Graham W ^a   Tallack, Michael R ^a   Gillinder, Kevin R ^a   Bell, Charles C ^a   McCallum, Naomi ^b   Williams, Bronwyn ^c   Perkins, Andrew C ^a,d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Pathology Queensland   (Australia)

^c ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^d PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; GLOBIN; HEME; HEMOGLOBIN; HEMOGLOBIN F; KINESIN; KINESIN LIKE PROTEIN 11; KINESIN LIKE PROTEIN 23; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 1; RNA; TRANSCRIPTOME; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ERYTHROID KRUPPEL-LIKE FACTOR;

ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; AUTOPHAGY; CELL CYCLE REGULATION; CHILD; CHILDHOOD; CLINICAL ARTICLE; CONGENITAL DYSERYTHROPOIETIC ANEMIA; CONTROLLED STUDY; CYTOKINESIS; CYTOSKELETON; DISEASE SEVERITY; ERYTHROBLAST; ERYTHROBLASTOSIS; ERYTHROCYTE; ERYTHROID CELL; FEMALE; FETUS HYDROPS; FETUS WASTAGE; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HEME SYNTHESIS; HEMOLYTIC ANEMIA; HEPATOSPLENOMEGALY; HETEROZYGOSITY; HUMAN; HUMAN CELL; INFANT; KERNICTERUS; MALE; NEWBORN; NEWBORN ANEMIA; NEWBORN JAUNDICE; PARENT; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; RNA SEQUENCE; YOUNG ADULT; BLOOD; CASE REPORT; COMPLICATION; ERYTHROPOIESIS; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

ANEMIA, NEONATAL; AUTOPHAGY; ERYTHROBLASTS; ERYTHROPOIESIS; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; HYDROPS FETALIS; INFANT, NEWBORN; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; TRANSCRIPTOME;

EID: 84927663453     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-08-590968     Document Type: Article

References (77)

1. Chui DH, Waye JS. Hydrops fetalis caused by alpha-thalassemia: an emerging health care problem. Blood. 1998;91(7):2213-2222.
2. Urbaniak SJ, Greiss MA. RhD haemolytic disease of the fetus and the newborn. Blood Rev. 2000;14(1):44-61.
3. Renella R, Wood WG. The congenital dyserythropoietic anemias. Hematol Oncol Clin North Am. 2009;23(2):283-306.
4. Iolascon A, Heimpel H, Wahlin A, Tamary H. Congenital dyserythropoietic anemias: molecular insights and diagnostic approach. Blood. 2013;122(13):2162-2166.
5. Wickramasinghe SN. Congenital dyserythropoietic anaemias: clinical features, haematological morphology and new biochemical data. Blood Rev. 1998;12(3):178-200.
6. Heimpel H, Matuschek A, Ahmed M, et al. Frequency of congenital dyserythropoietic anemias in Europe. Eur J Haematol. 2010;85(1):20-25.
7. Renella R, Roberts NA, Brown JM, et al. Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1alpha localization in erythroblasts. Blood. 2011;117(25):6928-6938.
8. Bianchi P, Fermo E, Vercellati C, et al. Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene. Hum Mutat. 2009;30(9):1292-1298.
9. Liljeholm M, Irvine AF, Vikberg AL, et al. Congenital dyserythropoietic anemia type III (CDA III) is caused by a mutation in kinesin family member, KIF23. Blood. 2013;121(23):4791-4799.
10. Parsons SF, Jones J, Anstee DJ, et al. A novel form of congenital dyserythropoietic anemia associated with deficiency of erythroid CD44 and a unique blood group phenotype [In(a-b-), Co(a-b-)]. [In(a-b-), Co(a-b-)] Blood. 1994;83(3):860-868.
11. Arnaud L, Saison C, Helias V, et al. A dominant mutation in the gene encoding the erythroid transcription factor KLF1 causes a congenital dyserythropoietic anemia. Am J Hum Genet. 2010;87(5):721-727.
12. Jaffray JA, Mitchell WB, Gnanapragasam MN, et al. Erythroid transcription factor EKLF/KLF1 mutation causing congenital dyserythropoietic anemia type IV in a patient of Taiwanese origin: review of all reported cases and development of a clinical diagnostic paradigm. Blood Cells Mol Dis. 2013;51(2):71-75.
13. Nuez B, Michalovich D, Bygrave A, Ploemacher R, Grosveld F. Defective haematopoiesis in fetal liver resulting from inactivation of the EKLF gene. Nature. 1995;375(6529):316-318.
14. Perkins AC, Sharpe AH, Orkin SH. Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF. Nature. 1995;375(6529):318-322.
15. Siatecka M, Bieker JJ. The multifunctional role of EKLF/KLF1 during erythropoiesis. Blood. 2011;118(8):2044-2054.
16. Tallack MR, Perkins AC. KLF1 directly coordinates almost all aspects of terminal erythroid differentiation. IUBMB Life. 2010;62(12):886-890.
17. Borg J, Papadopoulos P, Georgitsi M, et al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet. 2010;42(9):801-805.
18. Singleton BK, Burton NM, Green C, Brady RL, Anstee DJ. Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype. Blood. 2008;112(5):2081-2088.
19. Viprakasit V, Ekwattanakit S, Riolueang S, et al. Mutations in Kruppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression. Blood. 2014;123(10):1586-1595.
20. Liu D, Zhang X, Yu L, et al. KLF1 mutations are relatively more common in a thalassemia endemic region and ameliorate the severity of β-thalassemia. Blood. 2014;124(5):803-811.
21. Helias V, Saison C, Peyrard T, et al. Molecular analysis of the rare in(Lu) blood type: toward decoding the phenotypic outcome of haploinsufficiency for the transcription factor KLF1. Hum Mutat. 2013;34(1):221-228.
22. Wijgerde M, Gribnau J, Trimborn T, et al. The role of EKLF in human beta-globin gene competition. Genes Dev. 1996;10(22):2894-2902.
23. Perkins AC, Gaensler KM, Orkin SH. Silencing of human fetal globin expression is impaired in the absence of the adult beta-globin gene activator protein EKLF. Proc Natl Acad Sci U S A. 1996;93(22):12267-12271.
24. Tallack MR, Perkins AC. Three fingers on the switch: Krüppel-like factor 1 regulation of γ-globin to β-globin gene switching. Curr Opin Hematol. 2013;20(3):193-200.
25. Zhou D, Liu K, Sun CW, Pawlik KM, Townes TM. KLF1 regulates BCL11A expression and gamma-to beta-globin gene switching. Nat Genet. 2010;42(9):742-744.
26. Tallack MR, Whitington T, Yuen WS, et al. A global role for KLF1 in erythropoiesis revealed by ChIP-seq in primary erythroid cells. Genome Res. 2010;20(8):1052-1063.
27. Nilson DG, Sabatino DE, Bodine DM, Gallagher PG. Major erythrocyte membrane protein genes in EKLF-deficient mice. Exp Hematol. 2006;34(6):705-712.
28. Hodge D, Coghill E, Keys J, et al. A global role for EKLF in definitive and primitive erythropoiesis. Blood. 2006;107(8):3359-3370.
29. Tallack MR, Magor GW, Dartigues B, et al. Novel roles for KLF1 in erythropoiesis revealed by mRNA-seq. Genome Res. 2012;22(12):2385-2398.
30. Pilon AM, Ajay SS, Kumar SA, et al; NISC Comparative Sequencing Center. Genome-wide ChIP-Seq reveals a dramatic shift in the binding of the transcription factor erythroid Kruppel-like factor during erythrocyte differentiation. Blood. 2011;118(17):e139-e148.
31. Björkstén B, Holmgren G, Roos G, Stenling R. Congenital dyserythropoietic anaemia type III: an electron microscopic study. Br J Haematol. 1978;38(1):37-42.
32. Sigler E, Shaft D, Shtalrid M, Shvidel L, Berrebi A, Resnitzky P. New sporadic case of congenital dyserythropoietic anemia type III in an aged woman: detailed description of ultrastructural findings. Am J Hematol. 2002;70(1):72-76.
33. Tamary H, Offret H, Dgany O, et al. Congenital dyserythropoietic anaemia, type I, in a Caucasian patient with retinal angioid streaks (homozygous Arg1042Trp mutation in codanin-1). Eur J Haematol. 2008;80(3):271-274.
34. Singleton BK, Lau W, Fairweather VS, et al. Mutations in the second zinc finger of human EKLF reduce promoter affinity but give rise to benign and disease phenotypes. Blood. 2011;118(11):3137-3145.
35. Perkins AC, Gaensler KML, Orkin SH. Silencing of human fetal globin expression is impaired in the absence of the adult beta-globin gene activator protein EKLF. Proc Natl Acad Sci USA. 1996;93(22):12267-12271.
36. Pimentel H, Parra M, Gee S, et al. A dynamic alternative splicing program regulates gene expression during terminal erythropoiesis. Nucleic Acids Res. 2014;42(6):4031-4042.
37. Su MY, Steiner LA, Bogardus H, et al. Identification of biologically relevant enhancers in human erythroid cells. J Biol Chem. 2013;288(12):8433-8444.
38. Frontelo P, Manwani D, Galdass M, et al. Novel role for EKLF in megakaryocyte lineage commitment. Blood. 2007;110(12):3871-3880.
39. Siatecka M, Xue L, Bieker JJ. Sumoylation of EKLF promotes transcriptional repression and is involved in inhibition of megakaryopoiesis. Mol Cell Biol. 2007;27(24):8547-8560.
40. Palstra RJ, Tolhuis B, Splinter E, Nijmeijer R, Grosveld F, de Laat W. The beta-globin nuclear compartment in development and erythroid differentiation. Nat Genet. 2003;35(2):190-194.
41. Stadhouders R, Aktuna S, Thongjuea S, et al. HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers. J Clin Invest. 2014;124(4):1699-1710.
42. Bianchi E, Zini R, Salati S, et al. c-myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. Blood. 2010;116(22):e99-e110.
43. Wahlberg K, Jiang J, Rooks H, et al. The HBS1LMYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells. Blood. 2009;114(6):1254-1262.
44. Bauer DE, Kamran SC, Lessard S, et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science. 2013;342(6155):253-257.
45. Pilon AM, Arcasoy MO, Dressman HK, et al. Failure of terminal erythroid differentiation in EKLF-deficient mice is associated with cell cycle perturbation and reduced expression of E2F2. Mol Cell Biol. 2008;28(24):7394-7401.
46. Ye TZ, Gordon CT, Lai YH, et al. Ermap, a gene coding for a novel erythroid specific adhesion/receptor membrane protein. Gene. 2000;242(1-2):337-345.
47. Montel-Hagen A, Sitbon M, Taylor N. Erythroid glucose transporters. Curr Opin Hematol. 2009;16(3):165-172.
48. Flatt JF, Guizouarn H, Burton NM, et al. Stomatin-deficient cryohydrocytosis results from mutations in SLC2A1: a novel form of GLUT1 deficiency syndrome. Blood. 2011;118(19):5267-5277.
49. Xue L, Galdass M, Gnanapragasam MN, Manwani D, Bieker JJ. Extrinsic and intrinsic control by EKLF (KLF1) within a specialized erythroid niche. Development. 2014;141(11):2245-2254.
50. Qiu Z, Dubin AE, Mathur J, et al. SWELL1, a plasma membrane protein, is an essential component of volume-regulated anion channel. Cell. 2014;157(2):447-458.
51. Tallack MR, Keys JR, Humbert PO, Perkins AC. EKLF/KLF1 controls cell cycle entry via direct regulation of E2f2. J Biol Chem. 2009;284(31):20966-20974.
52. Tallack MR, Keys JR, Perkins AC. Erythroid Kruppel-like factor regulates the G1 cyclin dependent kinase inhibitor p18INK4c. J Mol Biol. 2007;369(2):313-321.
53. Siatecka M, Lohmann F, Bao S, Bieker JJ. EKLF directly activates the p21WAF1/CIP1 gene by proximal promoter and novel intronic regulatory regions during erythroid differentiation. Mol Cell Biol. 2010;30(11):2811-2822.
54. Vladimirou E, Mchedlishvili N, Gasic I, et al. Nonautonomous movement of chromosomes in mitosis. Dev Cell. 2013;27(1):60-71.
55. Singh S, Dev A, Verma R, et al. Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation. PLoS ONE. 2012;7(7):e38530.
56. Yocum AO, Steiner LA, Seidel NE, et al. A tissue-specific chromatin loop activates the erythroid ankyrin-1 promoter. Blood. 2012;120(17):3586-3593.
57. Salem H, Rachmin I, Yissachar N, et al. Nek7 kinase targeting leads to early mortality, cytokinesis disturbance and polyploidy. Oncogene. 2010;29(28):4046-4057.
58. Marinkovic D, Zhang X, Yalcin S, et al. Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J Clin Invest. 2007;117(8):2133-2144.
59. Turner J, Crossley M. Cloning and characterization of mCtBP2, a co-repressor that associates with basic Krüppel-like factor and other mammalian transcriptional regulators. EMBO J. 1998;17(17):5129-5140.
60. Cheng AW, Shi J, Wong P, et al. Muscleblind-like 1 (Mbnl1) regulates pre-mRNA alternative splicing during terminal erythropoiesis. Blood. 2014;124(4):598-610.
61. Wang J, Ramirez T, Ji P, Jayapal SR, Lodish HF, Murata-Hori M. Mammalian erythroblast enucleation requires PI3K-dependent cell polarization. J Cell Sci. 2012;125(Pt 2):340-349.
62. Ji P, Jayapal SR, Lodish HF. Enucleation of cultured mouse fetal erythroblasts requires Rac GTPases and mDia2. Nat Cell Biol. 2008;10(3):314-321.
63. Bogacheva O, Bogachev O, Menon M, et al. DYRK3 dual-specificity kinase attenuates erythropoiesis during anemia. J Biol Chem. 2008;283(52):36665-36675.
64. Zhao B, Keerthivasan G, Mei Y, et al. Targeted shRNA screening identified critical roles of pleckstrin-2 in erythropoiesis. Haematologica. 2014;99(7):1157-1167.
65. Griffiths RE, Kupzig S, Cogan N, et al. The ins and outs of human reticulocyte maturation: autophagy and the endosome/exosome pathway. Autophagy. 2012;8(7):1150-1151.
66. Nazio F, Strappazzon F, Antonioli M, et al. mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6. Nat Cell Biol. 2013;15(4):406-416.
67. Betin VM, Singleton BK, Parsons SF, Anstee DJ, Lane JD. Autophagy facilitates organelle clearance during differentiation of human erythroblasts: evidence for a role for ATG4 paralogs during autophagosome maturation. Autophagy. 2013;9(6):881-893.
68. Joo JH, Dorsey FC, Joshi A, et al. Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagy. Mol Cell. 2011;43(4):572-585.
69. Perseu L, Satta S, Moi P, et al. KLF1 gene mutations cause borderline HbA(2). Blood. 2011;118(16):4454-4458.
70. Drissen R, Palstra RJ, Gillemans N, et al. The active spatial organization of the beta-globin locus requires the transcription factor EKLF. Genes Dev. 2004;18(20):2485-2490.
71. Turner J, Crossley M. Basic Krüppel-like factor functions within a network of interacting haematopoietic transcription factors. [In Process Citation] Int J Biochem Cell Biol. 1999;31(10):1169-1174.
72. Funnell AP, Mak KS, Twine NA, et al. Generation of mice deficient in both KLF3/BKLF and KLF8 reveals a genetic interaction and a role for these factors in embryonic globin gene silencing. Mol Cell Biol. 2013;33(15):2976-2987.
73. Cohen-Barak O, Erickson DT, Badowski MS, et al. Stem cell transplantation demonstrates that Sox6 represses epsilon y globin expression in definitive erythropoiesis of adult mice. Exp Hematol. 2007;35(3):358-367.
74. Yi Z, Cohen-Barak O, Hagiwara N, et al. Sox6 directly silences epsilon globin expression in definitive erythropoiesis. PLoS Genet. 2006;2(2):e14.
75. Dumitriu B, Patrick MR, Petschek JP, et al. Sox6 cell-autonomously stimulates erythroid cell survival, proliferation, and terminal maturation and is thereby an important enhancer of definitive erythropoiesis during mouse development. Blood. 2006;108(4):1198-1207.
76. Murakami A, Ishida S, Thurlow J, Revest JM, Dickson C. SOX6 binds CtBP2 to repress transcription from the Fgf-3 promoter. Nucleic Acids Res. 2001;29(16):3347-3355.
77. Xu J, Sankaran VG, Ni M, et al. Transcriptional silencing of gamma-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev. 2010;24(8):783-798.